350% Upside. Favorable Descending Triangle.It has been in that triangle for almost 2 years now. Tagged the bottom of the triangle multiple times and could break upward out of the triangle. And RFK jr. policies favor this.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−15.85 MXN
−683.21 M MXN
5.33 M MXN
117.06 M
About ATAI Life Sciences N.V.
Sector
Headquarters
Berlin
Founded
2018
Website
ISIN
NL0015000DX5
FIGI
BBG015LH5L68
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany.
ATAI Life Sciences | ATAI | Long at $1.30ATAI Life Sciences NASDAQ:ATAI , a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, is fast approaching my selected historical simple moving average (SMA). Often, but not always, the closer the price gets to this line, the higher chance there is
High potential over the coming yearsPositioned to disrupt the medicinal industry with its wide range of products and significant stakes in other biotech companies like Compass. ATAI possess ample funds to quickly become a leader in a market that has not yet fully emerged. High Volatility I wouldn't be surprised to see the stock reach
ATAI - 2 potential paths to $5After successfully surpassing the previous swing high with considerable volume, attaining a fresh 52-week peak of $2.85, and witnessing the 50-day moving averages intersecting the 150 and 200 SMAs, ATAI appears poised for a reversal from its downtrend.
**Potential Scenarios:**
**Scenario 1: Triang
ATAI looking to bottom out
After closely monitoring psychedelic stocks for approximately six months, my attention has been drawn to ATAI. Despite enduring a challenging period over the past couple of years, the stock appears to be signaling a potential turnaround.
Volume Analysis
A notable observation is the diminishing v
similar to mindmed mush and psychedelics have good opportunity The opportunity is there, again similar to mmed stock. Mush and pyschadelics have a good potential in future. Bullish on this stock. just waiting for the correct technical set up. Might have to wait a few weeks for a play. but seems decent
ataiATAI LIFE SCIENCES. MUSHROOMS CLEARED MY ALCOHOL ADDICTION THIS YEAR, PSYCHEDILICS ARE THE REAL CURE FOR ADDICTION ANXIETY DEPRESSION ETC. This is one of the top companies.
This isn't a trade for me, I plan on holding long term but this is a very nice set up.
ATAI short-term playHello bulls,
This one is a short-term play and can't much be said about it.
After CMPS crushed, price dropped to 12$ and then due to Macro economical panic, crabbed around 11$.
This is good that it's crabbing around 11$ because the next steps are the slow stairs to the 15$.
Volume on last hour of D
$ATAI consolidating from wedge breakoutThis is one that I really look forward to. My conviction is fueled by the following:
- Belief in small mid caps outperforming following weeks
- Observation that new IPOs breaking out of downward wedge seem to be high probability plays
- All the short squeeze momo plays have a high chance of rotating
ATAI - long psychedelics If youre interessted or believe in psychedelics as medicine, its maybe a good buying oppurtunity for a longshot in ATAI. You could play it with a stop or not - personally I dont have a stop but checking it manually - if the level hold it can be a great longterm oppurtunity - personally I have a smal
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ATAI/N is 26.40 MXN — it has decreased by −19.63% in the past 24 hours. Watch ATAI LIFE SCIENCES NV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange ATAI LIFE SCIENCES NV stocks are traded under the ticker ATAI/N.
ATAI/N stock has fallen by −19.63% compared to the previous week, the month change is a 15.28% rise, over the last year ATAI LIFE SCIENCES NV has showed a −25.70% decrease.
We've gathered analysts' opinions on ATAI LIFE SCIENCES NV future price: according to them, ATAI/N price has a max estimate of 224.11 MXN and a min estimate of 101.87 MXN. Watch ATAI/N chart and read a more detailed ATAI LIFE SCIENCES NV stock forecast: see what analysts think of ATAI LIFE SCIENCES NV and suggest that you do with its stocks.
ATAI/N reached its all-time high on Mar 3, 2022 with the price of 113.07 MXN, and its all-time low was 22.90 MXN and was reached on Oct 31, 2024. View more price dynamics on ATAI/N chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ATAI/N stock is 24.43% volatile and has beta coefficient of 1.84. Track ATAI LIFE SCIENCES NV stock price on the chart and check out the list of the most volatile stocks — is ATAI LIFE SCIENCES NV there?
Today ATAI LIFE SCIENCES NV has the market capitalization of 4.06 B, it has decreased by −5.19% over the last week.
Yes, you can track ATAI LIFE SCIENCES NV financials in yearly and quarterly reports right on TradingView.
ATAI LIFE SCIENCES NV is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
ATAI/N earnings for the last quarter are −3.15 MXN per share, whereas the estimation was −3.15 MXN resulting in a 0.00% surprise. The estimated earnings for the next quarter are −2.91 MXN per share. See more details about ATAI LIFE SCIENCES NV earnings.
ATAI LIFE SCIENCES NV revenue for the last quarter amounts to 0.00 MXN, despite the estimated figure of 0.00 MXN. In the next quarter, revenue is expected to reach 6.05 M MXN.
ATAI/N net income for the last quarter is −517.93 M MXN, while the quarter before that showed −1.05 B MXN of net income which accounts for 50.73% change. Track more ATAI LIFE SCIENCES NV financial stats to get the full picture.
No, ATAI/N doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 83.00 employees. See our rating of the largest employees — is ATAI LIFE SCIENCES NV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ATAI LIFE SCIENCES NV EBITDA is −2.08 B MXN, and current EBITDA margin is −39.86 K%. See more stats in ATAI LIFE SCIENCES NV financial statements.
Like other stocks, ATAI/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ATAI LIFE SCIENCES NV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ATAI LIFE SCIENCES NV technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ATAI LIFE SCIENCES NV stock shows the sell signal. See more of ATAI LIFE SCIENCES NV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.